We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close


Q&A With Labaton Sucharow's Bernard Persky

Law360 (October 1, 2007, 12:00 AM EDT) -- A slowdown in pharmaceutical inflation is proof that the antitrust work of plaintiffs firms is benefiting consumers, Bernard Persky of Labaton Sucharow LLP tells Law360 in our series of chats with high-profile practice leaders.

Q. What attracted you to antitrust as a practice area? And what keeps you interested?

A. I was attracted to antitrust as a practice area for primarily two reasons. First, I was drawn to the intellectual rigor and challenges involved in litigating complex legal, factual and economic issues inherent in the practice...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.